Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs.  Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program.  The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.

The following faculty and planning committee have disclosed the following relationships with commercial interests:


April Armstrong, MD, MPH

Consultant: Abbvie, Eli Lilly, Janssen, Modernizing Medicine, Novartis, Pfizer, Regeneron, Sanofi, Ortho Dermatologics; Investigator: Abbvie, Eli Lilly, Janssen; Speaker's Bureau: Abbvie, Eli Lilly, Janssen

Wilson Liao, MD 

Investigator: Abbvie, Janssen, Novartis, Pfizer

Philip Mease, MD

Consultant: Abbvie, Amgen, Bristol Myers Squibb, Celgene, Janssen, Lilly, Novartis, Pfizer, Sun, UCB; Speaker: Abbvie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Janssen, Novartis, Pfizer, UCB; Research Grants: Abbvie, Amgen, Bristol Myers Squibb, Celgene, Janssen, Lily, Novartis, Pfizer, Sun, UCB


Planning Committee:  Susan Hardin, NPF Medical Programs Manager has no information to disclose.